)
)
Nyxoah Investor Relations Material
Latest events
Q3 2024
Nyxoah
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Nyxoah S.A.
Access all reports
Nyxoah S.A. is a medical technology company that specializes in developing and commercializing innovative treatments for Obstructive Sleep Apnea (OSA). The company's flagship product, the Genio system, offers a patient-centric and CE-Marked hypoglossal neurostimulation therapy designed to treat moderate to severe cases of OSA. This therapy serves as an alternative for patients who are unable or unwilling to tolerate Continuous Positive Airway Pressure (CPAP) treatments. The company is headquartered in Mont-Saint-Guibert, Belgium, and its shares are listed on the NASDAQ.
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
NYXH
Country
🇺🇸 United States